Navigation Links
A research tale with a heart to match: Professor looks at cardiovascular disease in dogs
Date:8/3/2011

MANHATTAN -- For more than 15 years, Kansas State University researcher Michele Borgarelli has studied heart diseases in man's best friend.

But there is an interesting twist in his work with mitral valve disease: chronic mitral valve disease in dogs is similar to the same disease affecting humans, making Borgarelli's research beneficial to dog's best friend, too.

Further proof of the bond between owner and dog? Perhaps.

But for Borgarelli, Kansas State University associate professor of cardiology, the heart-filled similarities motivate him to learn more about mitral valve disease, the most common acquired cardiovascular disease in dogs.

The disease is a heart condition where the mitral valve -- one of the four valves in the heart -- deteriorates. As the valve deteriorates, more blood backflows through the valve and can lead to congestive heart failure.

"We know that the disease affects geriatric dogs very commonly," Borgarelli said. "I'm interested to know why some dogs progress faster and die from the disease when other dogs do not."

Small breed dogs, such as Cavalier King Charles spaniels, cocker spaniels, dachshunds, miniature poodles and Yorkshire terriers are more prone to chronic mitral valve disease. But Borgarelli's research has shown that the disease can also affect large breed dogs, such as German shepherds. He wants to search a list of factors to identify dogs more likely to progress to a severe disease stage.

"Although a lot of these patients never progress to heart failure, you don't want to wait until they get to an age where it is too late," Borgarelli said. "You want to identify these patients as early as possible."

About 70 percent of the dogs that are affected by mitral valve disease are not affected from heart failure and do not die from the disease.

"That's very similar to people," Borgarelli said. "There are some people who don't progress to heart failure even without any treatment. Treatments options are also different between people and dogs. Severely afflicted humans can have their deteriorated valve repaired or replaced. You cannot do that with dogs, yet. But surgery is going to be an option in the future for dogs, and because not every dog will be affected by heart failure, it is important to be able to identify dogs at higher risk for progression of the disease."

During a period of five years, Borgarelli and his research team conducted two population studies that involve more than 300 dogs. One population study, which was published in 2008, involved dogs that had mitral valve disease at different stages, from mild to severe. Another study, which the researchers are preparing for publication, involves dogs with the mild form of the disease.

The researchers found that 70 percent of pre-clinical dogs that have symptoms of the disease are still alive after six years. The dogs that experience heart failure have a median survival time of nine months after severe heart failure to 33 months after moderate heart failure.

Using echocardiographic examination, which creates an ultrasound-like image of the heart, the researchers have already found some indicators for severe forms of the disease. One such indicator is an enlarged left atrium in the heart, while other indicators include biomarkers, which involve evaluating blood samples.

Borgarelli is leading an Italian study of another indicator, called Brain Natriuretic Peptide, or BNP. The study, which started last year and will last until 2015, has two major goals: to evaluate if treatment with a combination of two drugs can delay the onset of clinical signs of mitral valve disease and to evaluate if any biomarker, including the peptide, can be used to identify patient risk.

For a third study, Borgarelli is applying a new noninvasive technique called contrast echocardiography to evaluate noninvasive myocardial perfusion -- an imaging procedure that can evaluate many heart conditions.

The study, sponsored by pharmaceutical company Boehringer Ingelheim, has just begun at Kansas State University's College of Veterinary Medicine Teaching Hospital and will continue until 2012. Researchers plan additional studies using new 3D technology to further evaluate the mitral valve. Their work is evidence of the rapid progress made on the disease in recent years, Borgarelli said.

"This disease was first described in the 1960s. What we knew about the disease in the 1960s was about the same as what we knew up until a few years ago," Borgarelli said. "Many questions have been resolved in just a few years."

But unanswered questions still exist, Borgarelli said, such as whether the disease is genetic and why some dogs progress to a more severe disease while others do not.

"Because it's such a common disease and because dogs are naturally models for studying the disease in humans -- those are reasons why I want to continue studying this disease," Borgarelli said.


'/>"/>

Contact: Michele Borgarelli
mborgare@k-state.edu
785-532-4237
Kansas State University
Source:Eurekalert

Related medicine news :

1. Embedded Mobile & M2M Device revenues to Rise to Almost $19 Billion Globally by 2014, Says Juniper Research
2. 2010 HSR Impact Award recognizes surgical safety research
3. MSU launches first anti-counterfeiting research program
4. Researchers map all the fragile sites of the yeast Saccharomyces cerevisiaes genome
5. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
6. Researchers discover new way to kill pediatric brain tumors
7. Family Research Council: Planned Parenthood Report Oversexualizes Ten-Year-Olds, Undermines Parental Authority
8. Michael J. Fox Foundation Awards $1 Million to Drive Critical New Research Tools and Technologies in Parkinsons Drug Development
9. Luth Researchs IndicatorEDG(TM) Study Finds Americans Hopes of Achieving Their Dreams Are Fading
10. International Diabetes Federation awards $2 million to 9 global diabetes research projects
11. Gladstones Robert Mahley to receive Research!America advocacy award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort ... holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain ... Disease (SCD) is a disorder of the red blood cells, which can cause episodes ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, ... and the Road To Recovery® program to drive cancer patients to and from their ... to ensure the highest quality of life and ongoing independence. Getting to and ...
(Date:6/24/2016)... Las Vegas, Nevada (PRWEB) , ... June 24, ... ... their Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and ... The Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... India , June 24, 2016 ... Needles Market by Type (Standard Pen Needles, Safety Pen ... Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, ... by MarketsandMarkets, This report studies the market for the ... expected to reach USD 2.81 Billion by 2021 from ...
(Date:6/23/2016)... , June 23, 2016 Research and ... Global Market - Forecast to 2022" report to their ... treatment method for the patients with kidney failure, it replaces ... fluid from the patient,s blood and thus the treatment helps ... and chloride in balance. Increasing number of ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... Market Analysis 2016 - Forecast to 2022" report to ... report contains up to date financial data derived from varied ... major trends with potential impact on the market during the ... segmentation which comprises of sub markets, regional and country level ...
Breaking Medicine Technology: